Genzeon Named UiPath Partner of the Year for Healthcare
Genzeon has received UiPath's 2026 Industry Impact Partner of the Year award for Healthcare and Life Sciences. The recognition acknowledges the company's work in advancing AI-powered automation and delivering measurable outcomes.

Genzeon has been named UiPath's 2026 Industry Impact Partner of the Year for Healthcare and Life Sciences. The award, presented at UiPath FUSION 2026, recognizes Genzeon's contributions to helping healthcare organizations achieve measurable operational and financial results through AI and automation.
Over a five-year partnership, Genzeon has assisted healthcare entities in scaling automation across key processes such as prior authorizations, referrals, claims, and revenue cycle management. This has led to a reduction in manual tasks, enhanced accuracy, and accelerated processing times.
The company has demonstrated significant achievements, including within the CMS WISeR program, where its prior authorization infrastructure automates 85% to 90% of routine determinations. At a leading pediatric health system, a Genzeon-developed UiPath referral workflow reduced processing time from approximately six minutes to under one minute.
Genzeon operates as a UiPath Platinum Partner with a dedicated healthcare-focused business unit. The company has deployed over 45 AI agents and delivered more than 5,000 healthcare automation components as part of this collaboration.